Skip to main content

Cryopreservation and Revival of Human Mesenchymal Stromal Cells

  • Protocol
  • First Online:
Mesenchymal Stem Cells

Abstract

Cell-based therapy is a promising and innovative new treatment for different degenerative and autoimmune diseases, and mesenchymal stromal cells (MSCs) from the bone marrow have demonstrated great therapeutic potential due to their immunosuppressive and regenerative capacities.

The establishment of methods for large-scale expansion of clinical-grade MSCs in vitro has paved the way for their therapeutic use in clinical trials. However, the clinical application of MSCs also requires cryopreservation and banking of the cell products. To preserve autologous or allogeneic MSCs for future clinical applications, a reliable and effective cryopreservation method is required.

Developing a successful cryopreservation protocol for clinical stem cell products, cryopreservation media, cryoprotectant agents (CPAs), the freezing container, the freezing temperature, and the cooling and warming rate are all aspects which should be considered.

A major challenge is the selection of a suitable cryoprotectant which is able to penetrate the cells and yet has low toxicity.

This chapter focuses on recent technological developments relevant for the cryopreservation of MSCs using the most commonly used cryopreservation medium containing DMSO and animal serum or human-derived products for research use and the animal protein-free cryopreservation media CryoStor (BioLife Solutions) for clinical use.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Protocol
USD 49.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 149.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 199.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 279.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Bieback K, Kinzebach S, Karagianni M (2011) Translating research into clinical scale manufacturing of mesenchymal stromal cells. Stem Cells Int 2010:193519

    PubMed  PubMed Central  Google Scholar 

  2. Sensebe L, Bourin P, Tarte K (2011) Good manufacturing practices production of mesenchymal stem/stromal cells. Hum Gene Ther 22:19–26

    Article  CAS  PubMed  Google Scholar 

  3. Haack-Sorensen M, Friis T, Mathiasen AB et al (2013) Direct intramyocardial mesenchymal stromal cell injections in patients with severe refractory angina: one-year follow-up. Cell Transplant 22:521–528

    Article  PubMed  Google Scholar 

  4. Le BK, Frassoni F, Ball L et al (2008) Mesenchymal stem cells for treatment of steroid-resistant, severe, acute graft-versus-host disease: a phase II study. Lancet 371:1579–1586

    Article  Google Scholar 

  5. Mathiasen AB, Jorgensen E, Qayyum AA et al (2012) Rationale and design of the first randomized, double-blind, placebo-controlled trial of intramyocardial injection of autologous bone-marrow derived mesenchymal stromal cells in chronic ischemic heart failure (MSC-HF trial). Am Heart J 164:285–291

    Article  PubMed  Google Scholar 

  6. Ra JC, Kang SK, Shin IS et al (2011) Stem cell treatment for patients with autoimmune disease by systemic infusion of culture-expanded autologous adipose tissue derived mesenchymal stem cells. J Transl Med 9:181

    PubMed  PubMed Central  Google Scholar 

  7. Thirumala S, Goebel WS, Woods EJ (2013) Manufacturing and banking of mesenchymal stem cells. Expert Opin Biol Ther 13:673–691

    Article  CAS  PubMed  Google Scholar 

  8. Pegg DE (2015) Principles of cryopreservation. Methods Mol Biol 1257:3–19

    Article  CAS  PubMed  Google Scholar 

  9. Balci D, Can A (2013) The assessment of cryopreservation conditions for human umbilical cord stroma-derived mesenchymal stem cells towards a potential use for stem cell banking. Curr Stem Cell Res Ther 8:60–72

    Article  CAS  PubMed  Google Scholar 

  10. Janz FL, Debes AA, Cavaglieri RC et al (2012) Evaluation of distinct freezing methods and cryoprotectants for human amniotic fluid stem cells cryopreservation. J Biomed Biotechnol 2012:649353

    Article  PubMed Central  Google Scholar 

  11. Thirumala S, Goebel WS, Woods EJ (2009) Clinical grade adult stem cell banking. Organogenesis 5:143–154

    Article  PubMed  PubMed Central  Google Scholar 

  12. Li Y, Lu RH, Luo GF, Pang WJ et al (2006) Effects of different cryoprotectants on the viability and biological characteristics of porcine preadipocyte. Cryobiology 53:240–247

    Article  CAS  PubMed  Google Scholar 

  13. Liu Y, Xu X, Ma X et al (2010) Cryopreservation of human bone marrow-derived mesenchymal stem cells with reduced dimethylsulfoxide and well-defined freezing solutions. Biotechnol Prog 26:1635–1643

    Article  CAS  PubMed  Google Scholar 

  14. Rowley SD, Feng Z, Chen L et al (2003) A randomized phase III clinical trial of autologous blood stem cell transplantation comparing cryopreservation using dimethylsulfoxide vs dimethylsulfoxide with hydroxyethylstarch. Bone Marrow Transplant 31:1043–1051

    Article  CAS  PubMed  Google Scholar 

  15. Thirumala S, Gimble JM, Devireddy RV (2010) Evaluation of methylcellulose and dimethyl sulfoxide as the cryoprotectants in a serum-free freezing media for cryopreservation of adipose-derived adult stem cells. Stem Cells Dev 19:513–522

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  16. Freimark D, Sehl C, Weber C et al (2011) Systematic parameter optimization of a Me(2)SO- and serum-free cryopreservation protocol for human mesenchymal stem cells. Cryobiology 63:67–75

    Article  CAS  PubMed  Google Scholar 

  17. Ginis I, Grinblat B, Shirvan MH (2012) Evaluation of bone marrow-derived mesenchymal stem cells after cryopreservation and hypothermic storage in clinically safe medium. Tissue Eng Part C Methods 18:453–463

    Article  CAS  PubMed  Google Scholar 

  18. Woods EJ, Thirumala S (2011) Packaging considerations for biopreservation. Transfus Med Hemother 38:149–156

    Article  PubMed  PubMed Central  Google Scholar 

  19. Acker JP, Croteau IM (2004) Pre- and post-thaw assessment of intracellular ice formation. J Microsc 215(Pt 2):131–138

    Article  CAS  PubMed  Google Scholar 

  20. Heng BC (2009) Effect of Rho-associated kinase (ROCK) inhibitor Y-27632 on the post-thaw viability of cryopreserved human bone marrow-derived mesenchymal stem cells. Tissue Cell 41(5):376–380

    Article  CAS  PubMed  Google Scholar 

  21. Haack-Sorensen M, Friis T, Bindslev L et al (2008) Comparison of different culture conditions for human mesenchymal stromal cells for clinical stem cell therapy. Scand J Clin Lab Invest 68:192–203

    Article  CAS  PubMed  Google Scholar 

  22. Bieback K, Hecker A, Kocaomer A et al (2009) Human alternatives to fetal bovine serum for the expansion of mesenchymal stromal cells from bone marrow. Stem Cells 27:2331–2341

    Article  CAS  PubMed  Google Scholar 

  23. Castiglia S, Mareschi K, Labanca L et al (2014) Inactivated human platelet lysate with psoralen: a new perspective for mesenchymal stromal cell production in good manufacturing practice conditions. Cytotherapy 16:750–763

    Article  CAS  PubMed  Google Scholar 

  24. Perez-Ilzarbe M, Diez-Campelo M, Aranda P et al (2009) Comparison of ex vivo expansion culture conditions of mesenchymal stem cells for human cell therapy. Transfusion 49:1901–1910

    Article  CAS  PubMed  Google Scholar 

  25. Hubel A (2001) Cryopreservation of HPCs for clinical use. Transfusion 41:579–580

    Article  CAS  PubMed  Google Scholar 

  26. Mamidi MK, Singh G, Husin JM et al (2012) Impact of passing mesenchymal stem cells through smaller bore size needles for subsequent use in patients for clinical or cosmetic indications. J Transl Med 10:229

    Article  PubMed  PubMed Central  Google Scholar 

  27. Carvalho KA, Cury CC, Oliveira L et al (2008) Evaluation of bone marrow mesenchymal stem cell standard cryopreservation procedure efficiency. Transplant Proc 40:839–841

    Article  CAS  PubMed  Google Scholar 

  28. Cox MA, Kastrup J, Hrubisko M (2012) Historical perspectives and the future of adverse reactions associated with haemopoietic stem cells cryopreserved with dimethyl sulfoxide. Cell Tissue Bank 13:203–215

    Article  CAS  PubMed  Google Scholar 

  29. Hirata AA (1968) Cytolytic antibody assay by tryptic digestion of injured cells and electronic counting. J Immunol 91:625–632

    Google Scholar 

Download references

Acknowledgments

The Aase and Ejnar Danielsens Foundation and the Research Foundation at Rigshospitalet supported the development of this protocol.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Mandana Haack-Sørensen M.Sc., Ph.D. .

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2016 Springer Science+Business Media New York

About this protocol

Cite this protocol

Haack-Sørensen, M., Ekblond, A., Kastrup, J. (2016). Cryopreservation and Revival of Human Mesenchymal Stromal Cells. In: Gnecchi, M. (eds) Mesenchymal Stem Cells. Methods in Molecular Biology, vol 1416. Humana Press, New York, NY. https://doi.org/10.1007/978-1-4939-3584-0_21

Download citation

  • DOI: https://doi.org/10.1007/978-1-4939-3584-0_21

  • Published:

  • Publisher Name: Humana Press, New York, NY

  • Print ISBN: 978-1-4939-3582-6

  • Online ISBN: 978-1-4939-3584-0

  • eBook Packages: Springer Protocols

Publish with us

Policies and ethics